| Style | Citing Format |
|---|---|
| MLA | Heidari S M, Nazemroaya B, Farhanian P. "Comparing the Impact of Laryngoscopy on Hemodynamic Status and the Neutrophil-To-Lymphocyte Ratio After Induction of Anesthesia With Etomidate, Propofol, and Ketamine." Advanced Biomedical Research, vol. 15, no. 1, 2026, pp. -. |
| APA | Heidari S M, Nazemroaya B, Farhanian P (2026). Comparing the Impact of Laryngoscopy on Hemodynamic Status and the Neutrophil-To-Lymphocyte Ratio After Induction of Anesthesia With Etomidate, Propofol, and Ketamine. Advanced Biomedical Research, 15(1), -. |
| Chicago | Heidari S M, Nazemroaya B, Farhanian P. "Comparing the Impact of Laryngoscopy on Hemodynamic Status and the Neutrophil-To-Lymphocyte Ratio After Induction of Anesthesia With Etomidate, Propofol, and Ketamine." Advanced Biomedical Research 15, no. 1 (2026): -. |
| Harvard | Heidari S M, Nazemroaya B, Farhanian P (2026) 'Comparing the Impact of Laryngoscopy on Hemodynamic Status and the Neutrophil-To-Lymphocyte Ratio After Induction of Anesthesia With Etomidate, Propofol, and Ketamine', Advanced Biomedical Research, 15(1), pp. -. |
| Vancouver | Heidari S M, Nazemroaya B, Farhanian P. Comparing the Impact of Laryngoscopy on Hemodynamic Status and the Neutrophil-To-Lymphocyte Ratio After Induction of Anesthesia With Etomidate, Propofol, and Ketamine. Advanced Biomedical Research. 2026;15(1):-. |
| BibTex | @article{ author = {Heidari S M and Nazemroaya B and Farhanian P}, title = {Comparing the Impact of Laryngoscopy on Hemodynamic Status and the Neutrophil-To-Lymphocyte Ratio After Induction of Anesthesia With Etomidate, Propofol, and Ketamine}, journal = {Advanced Biomedical Research}, volume = {15}, number = {1}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Heidari S M AU - Nazemroaya B AU - Farhanian P TI - Comparing the Impact of Laryngoscopy on Hemodynamic Status and the Neutrophil-To-Lymphocyte Ratio After Induction of Anesthesia With Etomidate, Propofol, and Ketamine JO - Advanced Biomedical Research VL - 15 IS - 1 SP - EP - PY - 2026 ER - |